These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1996215)

  • 21. Malignant hyperthermia.
    Kaus SJ; Rockoff MA
    Pediatr Clin North Am; 1994 Feb; 41(1):221-37. PubMed ID: 8295804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant hyperthermia: experience in the prospective management of eight children.
    Dubrow TJ; Wackym PA; Abdul-Rasool IH; Moore TC
    J Pediatr Surg; 1989 Feb; 24(2):163-6. PubMed ID: 2724006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current concepts of malignant hyperthermia.
    Jafek BW; Solomons CC; Masson NC; Mahowald MC; Gumprecht TF
    Otolaryngol Head Neck Surg; 1981; 89(6):891-7. PubMed ID: 6801585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant hyperthermia, a Scandinavian update.
    Broman M; Islander G; Müller CR
    Acta Anaesthesiol Scand; 2015 Sep; 59(8):951-61. PubMed ID: 25989378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant hyperthermia: how to spot it early.
    Haslego SS
    RN; 2002 Jul; 65(7):31-5; quiz 36. PubMed ID: 12136527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis.
    O'Flynn RP; Shutack JG; Rosenberg H; Fletcher JE
    Anesthesiology; 1994 Jun; 80(6):1228-33. PubMed ID: 8010468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Onset of a fulminant malignant hyperthermia crisis. Case report of a 74-year-old patient with previously subclinical central core disease].
    Wejbora M; Bornemann-Cimenti H; Lessel D; Mandl C; Voit-Augustin H; Schwarz G
    Anaesthesist; 2013 Jan; 62(1):34-8. PubMed ID: 23247425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant hyperthermia--the perioperative nurse's role.
    Hommertzheim R; Steinke EE
    AORN J; 2006 Jan; 83(1):149-56, 159-60, 162-4; quiz 167-70. PubMed ID: 16528905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anesthetic malignant hyperthermia: what's new in 2012?].
    Nivoche Y; Bruneau B; Dahmani S
    Ann Fr Anesth Reanim; 2013 Jan; 32(1):e43-7. PubMed ID: 23290613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant hyperthermia.
    Halliday NJ
    J Craniofac Surg; 2003 Sep; 14(5):800-2. PubMed ID: 14501352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chapter 7 Investigations on the Relationship Between the Autonomic Nervous System and the Triggering of Malignant Hyperthermia: A State-of-the-Science Review.
    Perry SM
    Annu Rev Nurs Res; 2014; 32():135-54. PubMed ID: 25222541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Malignant hyperthermia].
    Chastonay P; Bracco D; Freymond D; Ravussin P
    Rev Med Suisse Romande; 1999 Mar; 119(3):191-202. PubMed ID: 10218414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current understanding of malignant hyperthermia: genesis, prevention, and treatment.
    Katz DN
    CRNA; 1992 May; 3(2):54-63. PubMed ID: 1483145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safe duration of postoperative monitoring for malignant hyperthermia susceptible patients.
    Pollock N; Langtont E; Stowell K; Simpson C; McDonnell N
    Anaesth Intensive Care; 2004 Aug; 32(4):502-9. PubMed ID: 15675210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nursing Interventions of Intraoperative Malignant Hyperthermia in Patients With Scoliosis: A Report of 3 Cases.
    An X; Wang Q; Qiu Y; Zhu Z; Ma Z; Hua W; Li X
    J Neurosci Nurs; 2020 Apr; 52(2):66-71. PubMed ID: 32049870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant hyperthermia: a potential crisis in the postanesthesia care unit.
    Ashby D
    J Post Anesth Nurs; 1990 Aug; 5(4):279-81. PubMed ID: 2388172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.
    Serfas KD; Bose D; Patel L; Wrogemann K; Phillips MS; MacLennan DH; Greenberg CR
    Anesthesiology; 1996 Feb; 84(2):322-9. PubMed ID: 8602662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant hyperthermia in a 3-month-old infant: a case report.
    Pennington GP; Joeris L
    J Med Assoc Ga; 1996 Sep; 85(3):162-3. PubMed ID: 8870451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group.
    Ording H; Brancadoro V; Cozzolino S; Ellis FR; Glauber V; Gonano EF; Halsall PJ; Hartung E; Heffron JJ; Heytens L; Kozak-Ribbens G; Kress H; Krivosic-Horber R; Lehmann-Horn F; Mortier W; Nivoche Y; Ranklev-Twetman E; Sigurdsson S; Snoeck M; Stieglitz P; Tegazzin V; Urwyler A; Wappler F
    Acta Anaesthesiol Scand; 1997 Sep; 41(8):955-66. PubMed ID: 9311391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using a Vulnerability Theoretical Model to Assess the Malignant Hyperthermia Susceptible Population: Implications for Advanced Practice Emergency Nurses.
    Denholm BG
    Adv Emerg Nurs J; 2015; 37(3):209-22. PubMed ID: 26218487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.